DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 160 filers reported holding DIPLOMAT PHARMACY INC in Q4 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $433,000 | -46.7% | 71,140 | +17.9% | 0.02% | -51.9% |
| Q4 2018 | $812,000 | -61.1% | 60,321 | -42.0% | 0.05% | -43.5% |
| Q4 2017 | $2,087,000 | +447.8% | 104,020 | +464.4% | 0.09% | +384.2% |
| Q3 2017 | $381,000 | -52.7% | 18,430 | -66.1% | 0.02% | -55.8% |
| Q2 2017 | $805,000 | -80.9% | 54,441 | -79.4% | 0.04% | -77.9% |
| Q1 2017 | $4,219,000 | +81.6% | 264,521 | +43.4% | 0.20% | +40.3% |
| Q4 2016 | $2,323,000 | +280.8% | 184,400 | +745.9% | 0.14% | -29.4% |
| Q3 2016 | $610,000 | -19.0% | 21,800 | +29.4% | 0.20% | +688.0% |
| Q2 2015 | $753,000 | -44.0% | 16,849 | -56.7% | 0.02% | -45.7% |
| Q1 2015 | $1,345,000 | +140.2% | 38,923 | +90.3% | 0.05% | +119.0% |
| Q4 2014 | $560,000 | – | 20,454 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |